Wednesday, July 13, 2011

• L.E.K. Consulting Profiles the New Face of Blockbuster Drugs

  BOSTON, MA -- (Marketwire) -- 07/13/11 -- L.E.K. Consulting today announced new findings that reveal how the blockbuster drug market is changing, project continued blockbuster shifts through 2015 and outline ramifications for biopharma and life sciences companies in the future. Blockbusters, defined as branded prescription drugs that generate more ... read more